BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20088012)

  • 21. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO; Saylors EK; Schneider JE; Jobe RL; Mann JT
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):533-8. PubMed ID: 18307224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between one-stent versus two-stent technique for treatment of left main bifurcation lesions: A large single-center data.
    Gao Z; Xu B; Yang Y; Qiao S; Wu Y; Chen T; Xu L; Yuan J; Chen J; Gao RL
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1132-8. PubMed ID: 25614097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging.
    Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ
    JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up after percutaneous treatment of the unprotected left main stenosis in high risk patients not suitable for bypass surgery.
    Gómez-Hospital JA; Gomez-Lara J; Rondan J; Homs S; Lozano Martínez-Luengas I; Ferreiro JL; Roura G; Maristany J; Teruel L; Carro A; Avanzas P; Jara P; Esplugas E; Moris C; Cequier A
    Rev Esp Cardiol (Engl Ed); 2012 Jun; 65(6):530-7. PubMed ID: 22521483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome in high risk patients with unprotected left main coronary artery stenosis treated with percutaneous coronary intervention.
    Jensen LO; Kaltoft A; Thayssen P; Tilsted HH; Christiansen EH; Mikkelsen KV; Maeng M; Hansen KN; Villadsen AB; Madsen M; Lassen JF; Pedersen KE; Thuesen L
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):101-8. PubMed ID: 19670299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergent versus elective percutaneous stent implantation in the unprotected left main: long-term outcomes from a single-center registry.
    Martin-Yuste V; Alvarez-Contreras L; Brugaletta S; Ferreira-Gonzalez I; Cola C; Garcia-Picart J; Martí V; Sabate M
    J Invasive Cardiol; 2011 Oct; 23(10):392-7. PubMed ID: 21972154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complexity of coronary artery disease affects outcome of patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Melina G; Angeloni E; Benedetto U; Monti F; Roscitano A; Serdoz R; Sinatra R
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):656-61. PubMed ID: 22995728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
    Akin I; Bufe A; Eckardt L; Reinecke H; Richardt G; Kuck KH; Senges J; Schneider S; Nienaber CA;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):50-7. PubMed ID: 20578192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex-related differences in patients undergoing percutaneous unprotected left main stenting.
    Sheiban I; La Spina C; Cavallero E; Biondi-Zoccai G; Colombo F; Palmerini T; Marzocchi A; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; di Pede F; Ramondo A; Fantoni C; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; de Servi S
    EuroIntervention; 2010 Feb; 5(7):795-800. PubMed ID: 20142193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
    Kim WJ; Kim YH; Park DW; Yun SC; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):775-82. PubMed ID: 21520380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
    Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE experience (the RUDI registry).
    Sardella G; Conti G; Bisceglia T; Canali E; Mancone M; De Carlo C; Spedicato L; Morocutti G; Fedele F; Bernardi G
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1068-75. PubMed ID: 21567883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
    Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
    JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term outcomes of implanting drug-eluting stents for unprotected left main coronary artery disease patients with left ventricular systolic dysfunction].
    Pan Y; Qiu Q; Ren WH; Yu XP; Li Q; Ren XJ
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(46):3612-3616. PubMed ID: 29275602
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry.
    Akin I; Naber C; Sabin G; Hochadel M; Senges J; Kuck KH; Nienaber C; Richardt G; Tölg R
    Clin Res Cardiol; 2013 Sep; 102(9):679-86. PubMed ID: 23681360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction.
    Sardi GL; Gaglia MA; Maluenda G; Torguson R; Laynez-Carnicero A; Ben-Dor I; Hauville C; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2012 Feb; 109(3):344-51. PubMed ID: 22112742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.